A clinical trial to compare the effect of clonidine administration by two different routes, intravenous and surgical site infiltration,on pain after gall bladder surgery
- Conditions
- Post surgical pain
- Registration Number
- CTRI/2012/12/003258
- Lead Sponsor
- Director
- Brief Summary
This randomized double- blind study was conducted to compare the postoperative analgesic effect of clonidine when administered intravenously or in wound infiltration with bupivacaine. 60 adult patients of ASA grade I-II undergoing elective open cholecystectomy were randomly allocated into three groups. Group 1 (control group) patients received wound infiltration with 30 ml 0.25% bupivacaine at the end of surgery. Group 2 patients received 3 mcg/kg clonidine IV plus wound infiltration with bupivacaine, while group 3 patients received 3 mcg/kg clonidine in would infiltration with bupivacaine. Postoperative analgesia was provided with intravenous diclofenac 8 hourly and morphine on demand. The postoperative pain, number of patients requiring rescue analgesia and total morphine consumption during 24 postoperative hours was recorded. Patients were observed for any adverse effects like excessive sedation, nausea-vomiting, hypotension and bradycardia.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
Patients posted for elective open cholecystectomy under general anesthesia.
Patients with ASA physical status 3 or 4, Patients with morbid obesity, patients receiving adrenoceptor agonist, antagonist or narcotics.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Postoperative pain and analgesic requirement 24 postoperative hours
- Secondary Outcome Measures
Name Time Method Side effects, like sedation, nausea-vomiting, hypotension and bradycardia Patients satisfaction score
Trial Locations
- Locations (1)
Department of Anesthesia
🇮🇳Chandigarh, CHANDIGARH, India
Department of Anesthesia🇮🇳Chandigarh, CHANDIGARH, IndiaNeerja BhartiPrincipal investigator9915575145bhartineerja@yahoo.com
